A genomics approach to females with infertility and recurrent pregnancy loss.

Fertilization failure Meiotic arrest Preimplantation embryonic lethality Primary ciliary dyskinesia Primary infertility Recurrent pregnancy loss

Journal

Human genetics
ISSN: 1432-1203
Titre abrégé: Hum Genet
Pays: Germany
ID NLM: 7613873

Informations de publication

Date de publication:
May 2020
Historique:
received: 29 12 2019
accepted: 19 02 2020
pubmed: 17 3 2020
medline: 28 4 2020
entrez: 16 3 2020
Statut: ppublish

Résumé

Infertility affects 10% of reproductive-age women and is extremely heterogeneous in etiology. The genetic contribution to female infertility is incompletely understood, and involves chromosomal and single-gene defects. Our aim in this study is to decipher single-gene causes in infertile women in whom endocrinological, anatomical, and chromosomal causes have been excluded. Our cohort comprises women with recurrent pregnancy loss and no offspring from spontaneous pregnancies (RPL, n = 61) and those who never achieved clinical pregnancy and were referred for in vitro fertilization [primary infertility (PI), n = 14]. Whole-exome sequencing revealed candidate variants in 14, which represents 43% of those with PI and 13% of those with RPL. These include variants in previously established female infertility-related genes (TLE6, NLRP7, FSHR, and ZP1) as well as genes with only tentative links in the literature (NLRP5). Candidate variants in genes linked to primary ciliary dyskinesia (DNAH11 and CCNO) were identified in individuals with and without systemic features of the disease. We also identified variants in genes not previously linked to female infertility. These include one homozygous variant each in CCDC68, CBX3, CENPH, PABPC1L, PIF1, PLK1, and REXO4, which we propose as candidate genes for infertility based on their established biology or compatible animal models. Our study expands the contribution of single genes to the etiology of PI and RPL, improves the precision of disease classification at the molecular level, and offers the potential for future treatment and development of human genetics-inspired fertility regulators.

Identifiants

pubmed: 32172300
doi: 10.1007/s00439-020-02143-5
pii: 10.1007/s00439-020-02143-5
doi:

Substances chimiques

Genetic Markers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

605-613

Références

Hum Genet. 2017 Aug;136(8):921-939
pubmed: 28600779
J Med Genet. 2019 Jul;56(7):471-480
pubmed: 30877238
N Engl J Med. 2014 Mar 27;370(13):1220-6
pubmed: 24670168
Biol Reprod. 2002 Aug;67(2):546-54
pubmed: 12135894
Biol Reprod. 2011 Nov;85(5):1013-24
pubmed: 21778144
Mol Genet Genomic Med. 2014 Sep;2(5):369-78
pubmed: 25333061
Am J Hum Genet. 2019 Dec 5;105(6):1102-1111
pubmed: 31679651
Clin Genet. 2017 Feb;91(2):344-345
pubmed: 27730629
Nat Genet. 2004 Jul;36(7):744-9
pubmed: 15208629
Am J Hum Genet. 1998 Jun;62(6):1282-7
pubmed: 9585621
Reprod Biomed Online. 2018 Jun;36(6):698-704
pubmed: 29606347
PLoS One. 2015 Feb 06;10(2):e0116783
pubmed: 25658810
Cell. 2011 May 27;145(5):678-91
pubmed: 21620135
J Clin Invest. 1998 Oct 1;102(7):1352-9
pubmed: 9769327
Genetics. 2019 Nov;213(3):835-847
pubmed: 31537623
J Assist Reprod Genet. 2019 Apr;36(4):741-747
pubmed: 30778819
Mol Cell Biol. 2008 Nov;28(22):6870-6
pubmed: 18794363
Hum Mutat. 2019 Nov;40(11):2001-2006
pubmed: 31292994
Nat Commun. 2014 Sep 11;5:4887
pubmed: 25208553
Hum Reprod. 2019 Nov 1;34(11):2201-2207
pubmed: 31734689
Dev Biol. 2000 Apr 15;220(2):392-400
pubmed: 10753525
Fertil Steril. 1998 Jul;70(1):30-4
pubmed: 9660416
Biochem J. 2012 Aug 15;446(1):47-58
pubmed: 22621333
Oncogene. 2011 Nov 24;30(47):4731-9
pubmed: 21602889
Nat Commun. 2017 Apr 19;8:15057
pubmed: 28422092
Hum Reprod. 2017 Sep 1;32(9):1786-1801
pubmed: 29117321
Hum Reprod. 2015 Dec;30(12):2871-80
pubmed: 26373788
Genome Biol. 2015 Nov 05;16:240
pubmed: 26537248
Nat Commun. 2019 Jul 12;10(1):3086
pubmed: 31300655
Eur Respir J. 2017 Nov 9;50(5):
pubmed: 29122913
Exp Suppl. 2019;111:367-383
pubmed: 31588540
Hum Reprod Update. 2008 Jul-Aug;14(4):293-307
pubmed: 18385259
Mol Biol Cell. 2012 Jun;23(12):2264-74
pubmed: 22535524
Epigenetics Chromatin. 2010 Apr 27;3(1):9
pubmed: 20423503
Am J Hum Genet. 2017 Oct 5;101(4):603-608
pubmed: 28965844

Auteurs

Sateesh Maddirevula (S)

Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Khalid Awartani (K)

Department of Obstetrics and Gynecology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Serdar Coskun (S)

Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center and College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

Latifa F AlNaim (LF)

Department of Obstetrics and Gynecology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Niema Ibrahim (N)

Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Firdous Abdulwahab (F)

Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Mais Hashem (M)

Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Saad Alhassan (S)

Department of Obstetrics and Gynecology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Fowzan S Alkuraya (FS)

Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. falkuraya@kfshrc.edu.sa.
Department of Anatomy and Cell Biology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia. falkuraya@kfshrc.edu.sa.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH